-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NMUSCJaXJv0bbHR/6yzxc8oRTMuNksTPTgR1rDlQulxojnhgD6LNp4veTjoScj9H WUkJMIvnG40XaGo8o5DpIA== 0001013594-09-001276.txt : 20090624 0001013594-09-001276.hdr.sgml : 20090624 20090624170640 ACCESSION NUMBER: 0001013594-09-001276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090622 FILED AS OF DATE: 20090624 DATE AS OF CHANGE: 20090624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 801 CORPORATE CENTER DRIVE STREET 2: SUITE 210 CITY: RALEIGH STATE: NC ZIP: 27607 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES, L.P. CENTRAL INDEX KEY: 0000904495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 09907913 BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: 712 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: ELLIOTT ASSOCIATES LP DATE OF NAME CHANGE: 19930513 4 1 bdsifm4-062409_ex.xml JUNE 24, 2009 X0303 4 2009-06-22 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0000904495 ELLIOTT ASSOCIATES, L.P. 712 FIFTH AVE NEW YORK NY 10019 0 0 1 0 Common Stock 2009-06-22 4 S 0 11657 6.5568 D 1109338 I See Common Stock 2009-06-23 4 S 0 32800 6.3036 D 1076538 I See Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation ("Manchester"), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. ("BDSI"), owned by CDC IV, LLC ("CDC IV"). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager's rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV. On June 22, 2009, CDC IV sold an aggregate of 11,657 shares of Common Stock of BDSI at an average gross price per share of $6.5568. The individual trades made by CDC IV on June 22, 2009 are set forth on Exhibit 1(a) attached hereto. On June 23, 2009, CDC IV sold an aggregate of 32,800 shares of Common Stock of BDSI at an average gross price per share of $6.3036. The individual trades made by CDC IV on June 23, 2009 are set forth on Exhibit 1(b) attached hereto. Elliot Greenberg, VP of Braxton Associates, Inc., as GP of Elliott Capital Advisors, L.P., as GP of Elliott Associates, L.P. 2009-06-24 EX-99 2 bdsiex99-062409.htm JUNE 24, 2009

EXHIBIT 1(a)
Trades on June 22, 2009
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date	2A.Deemed Execut ion Date, if any	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following	6. Ownership Form: Direct (D) or	7.Nature of Indirect Beneficial Ownership
	(Month/ Day/ Year)	(Month/ Day/ Year)	Code	V	Amount	(A)or (D)	Price	Reported Transaction(s) (Instr. 3 and 4)	Indirect (I) (Instr. 4)	(Instr. 4)
Common Stock	06/22/09		S		7,647	D	6.5500	1,113,348	I	(1)
Common Stock	06/22/09		S		100	D	6.5503	1,113,248	I	(1)
Common Stock	06/22/09		S		1,300	D	6.5600	1,111,948	I	(1)
Common Stock	06/22/09		S		300	D	6.5650	1,111,648	I	(1)
Common Stock	06/22/09		S		1,310	D	6.5700	1,110,338	I	(1)
Common Stock	06/22/09		S		700	D	6.5800	1,109,638	I	(1)
Common Stock	06/22/09		S		300	D	6.6000	1,109,338	I	(1)

EXHIBIT 1(b)
Trades on June 23, 2009
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date	2A.Deemed Execution Date, if any	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following	6. Ownership Form: Direct (D) or	7.Nature of Indirect Beneficial Ownership
	(Month/ Day/ Year)	(Month/ Day/ Year)	Code	V	Amount	(A)or (D)	Price	Reported Transaction(s) (Instr. 3 and 4)	Indirect (I) (Instr. 4)	(Instr. 4)
Common Stock	06/23/09		S		29,125	D	6.3000	1,080,213	I	(1)
Common Stock	06/23/09		S		200	D	6.3070	1,080,013	I	(1)
Common Stock	06/23/09		S		100	D	6.3075	1,079,913	I	(1)
Common Stock	06/23/09		S		100	D	6.3090	1,079,813	I	(1)
Common Stock	06/23/09		S		100	D	6.3100	1,079,713	I	(1)
Common Stock	06/23/09		S		625	D	6.3300	1,079,088	I	(1)
Common Stock	06/23/09		S		1,400	D	6.3350	1,077,688	I	(1)
Common Stock	06/23/09		S		1,150	D	6.3400	1,076,538	I	(1)

(1) Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation (“Manchester”), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. (“BDSI”), owned by CDC IV, LLC (“CDC IV”). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager’s rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV.

-----END PRIVACY-ENHANCED MESSAGE-----